Prothena Corporation plc - Ordinary Shares (PRTA): $22.78

-0.71 (-3.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRTA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 491

in industry

Prothena Corp Public Ltd Co (PRTA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PRTA.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $24 $11 $16.4 $24.6 -33.33%

The Trend in the Analyst Price Target


Over the past 34 days, PRTA's average price target has gone up $0.8.

PRTA reports an average of 26.76% for its upside potential over the past 175 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-06-02 6 19 11 13.83 11.52 20.05%
2020-07-07 7 19 11 14.14 10.70 32.15%
2020-07-13 6 16 11 13.33 11.65 14.42%
2020-07-21 6 16 11 13.33 12.90 3.33%
2020-08-07 6 20 11 14.67 12.72 15.33%
2020-10-21 5 24 11 15.60 11.95 30.54%
2020-11-05 5 24 11 16.40 13.73 19.45%
2020-11-15 4 24 11 17.50 12.30 42.28%
2020-11-23 5 24 11 16.40 11.50 42.61%
2020-11-24 5 24 11 16.40 11.12 47.48%

PRTA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.79 1 2 3 0 0 7

The Trend in the Broker Recommendations


list("500 - Internal server error")

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRTA as an investment opportunity.

  • The upside potential (average analyst target price relative to current price) of PRTA is higher than 4.74% of all US stocks.
  • Prothena Corp Public Ltd Co's variance in analysts' estimates is lower than 9.47% of stocks in the mid market cap category.
  • The average analyst price target of PRTA is higher than 20.7% of stocks in the mid market cap category.
  • Prothena Corp Public Ltd Co's number of analysts covering the stock is greater than 30.32% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, IRWD, SUPN and AMPH are the three stocks most similar to Prothena Corp Public Ltd Co regarding the price target and analyst recommendation information presented here.

What is the outlook for PRTA? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.1866 seconds.